Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Sarcoma 1Other solid neoplasm 1Head & Neck 1Genitourinary 1Dermatologic 1

Conditions

Lymphoma, T-Cell, Cutaneous 20Lymphoma, Large B-Cell, Diffuse 17Precursor Cell Lymphoblastic Leukemia-Lymphoma 15Lymphoma, Non-Hodgkin 15Lymphoma, Large-Cell, Immunoblastic 15Lymphoma, Follicular 15Leukemia, Lymphocytic, Chronic, B-Cell 15Burkitt Lymphoma 15Lymphoma, Mantle-Cell 14Lymphoma, B-Cell, Marginal Zone 14Sezary Syndrome 13Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 13Mycosis Fungoides 13Lymphoma 12Hodgkin Disease 12Waldenstrom Macroglobulinemia 11Lymphoma, Large-Cell, Anaplastic 11Immunoblastic Lymphadenopathy 11Lymphoma, Extranodal NK-T-Cell 9Recurrence 8Multiple Myeloma 7Lymphoma, T-Cell, Peripheral 7Leukemia, Myeloid, Acute 7Leukemia, Hairy Cell 7Intraocular Lymphoma 7Dendritic Cell Sarcoma, Interdigitating 7Primary Myelofibrosis 6Neoplasms, Plasma Cell 6Myeloproliferative Disorders 6Myelodysplastic Syndromes 6

Interventions

pembrolizumab 1niraparib 1montanide ISA 51 1flt3 ligand protein 1atezolizumab 1MART-1 Antigen 1Immunoglobulins, Intravenous 1Gemcitabine 1GSK-3326595 1Etoposide 1Cyclophosphamide 1Biological Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Urologic Neoplasms × Etoposide × Dermatologic × Clear all
NCT03420963 2026-03-20

Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors

M.D. Anderson Cancer Center

Phase 1 Terminated
12 enrolled
DermatologicGenitourinaryHead & NeckOther solid neoplasmSarcomaThoracic

Mesothelioma, Malignant, Bone Neoplasms, Endocrine Gland Neoplasms, Melanoma, Mouth Neoplasms, Pharyngeal Neoplasms, Sarcoma, Skin Neoplasms, Thyroid Neoplasms, Urologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡